News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
616,194 Results
Type
Article (41625)
Company Profile (338)
Press Release (574220)
Multimedia
Podcasts (132)
Webinars (22)
Section
Business (165259)
Career Advice (2430)
Deals (29880)
Drug Delivery (130)
Drug Development (78268)
Employer Resources (142)
FDA (14448)
Job Trends (12734)
News (292073)
Policy (27920)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (4)
2027 Genetown Standard (4)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2643)
Accelerated approval (55)
ADA (49)
Adcomms (35)
Allergies (195)
Alliances (42035)
ALS (225)
Alzheimer's disease (1892)
Antibody-drug conjugate (ADC) (530)
Approvals (14828)
Artificial intelligence (712)
ASCO (345)
Autoimmune disease (337)
Automation (49)
Bankruptcy (322)
Best Places to Work (10406)
BIOSECURE Act (17)
Biosimilars (217)
Biotechnology (253)
Bladder cancer (203)
Brain cancer (76)
Breast cancer (787)
Cancer (6211)
Cardiovascular disease (513)
Career advice (2074)
Career pathing (48)
CAR-T (361)
CDC (57)
Celiac Disease (1)
Cell therapy (979)
Cervical cancer (47)
Clinical research (68454)
Collaboration (2135)
Commercialization (1)
Company closure (6)
Compensation (1047)
Complete response letters (95)
COVID-19 (2676)
CRISPR (122)
C-suite (1247)
Cystic fibrosis (156)
Data (8503)
Decentralized trials (3)
Denatured (31)
Depression (185)
Dermatology (90)
Diabetes (648)
Diagnostics (6252)
Digital health (52)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (357)
Drug pricing (195)
Drug shortages (26)
Duchenne muscular dystrophy (311)
Earnings (66004)
Editorial (67)
Employer branding (19)
Employer resources (134)
Events (95386)
Executive appointments (1147)
FDA (18204)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (20)
Frontotemporal dementia (36)
Funding (1746)
Gene editing (262)
Generative AI (63)
Gene therapy (794)
GLP-1 (1123)
Government (4499)
Grass and pollen (7)
Guidances (411)
Healthcare (17082)
Hematology (175)
HIV (85)
Huntington's disease (61)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (113)
Immunology and inflammation (328)
Immuno-oncology (108)
Indications (202)
Infectious disease (3028)
Inflammatory bowel disease (232)
Inflation Reduction Act (16)
Influenza (127)
Intellectual property (305)
Interviews (527)
IPO (14129)
IRA (52)
Job creations (2652)
Job search strategy (1658)
JPM (66)
Kidney cancer (22)
Labor market (78)
Layoffs (561)
Leadership (49)
Legal (5811)
Liver cancer (104)
Longevity (31)
Lung cancer (847)
Lymphoma (456)
Machine learning (59)
Management (52)
Manufacturing (1024)
Marketing (1)
MASH (224)
Medical affairs (1)
Medical device (11302)
Medtech (11426)
Mergers & acquisitions (16956)
Metabolic disorders (1665)
mRNA (237)
Multiple sclerosis (192)
NASH (23)
Neurodegenerative disease (473)
Neuropsychiatric disorders (123)
Neuroscience (3552)
Neurotech (1)
NextGen: Class of 2026 (5751)
Non-profit (4018)
Now hiring (73)
Obesity (767)
Opinion (321)
Ovarian cancer (238)
Pain (262)
Pancreatic cancer (333)
Parkinson's disease (401)
Partnered (33)
Patents (610)
Patient recruitment (732)
Peanut (67)
People (55866)
Pharmaceutical (49)
Pharmacy benefit managers (23)
Phase 1 (21594)
Phase 2 (30319)
Phase 3 (22425)
Pipeline (9381)
Policy (325)
Postmarket research (2297)
Preclinical (9079)
Press Release (59)
Prostate cancer (332)
Psychedelics (66)
Radiopharmaceuticals (352)
Rare diseases (1193)
Real estate (4366)
Recruiting (58)
Regulatory (23155)
Reports (33)
Research institute (2282)
Resumes & cover letters (351)
Rett syndrome (43)
RNA editing (30)
RSV (83)
Schizophrenia (193)
Series A (299)
Series B (224)
Service/supplier (2)
Sickle cell disease (123)
Special edition (26)
Spinal muscular atrophy (173)
Sponsored (44)
Startups (3155)
State (2)
Stomach cancer (19)
Supply chain (115)
Tariffs (78)
The Weekly (99)
Vaccines (1089)
Venture capital (118)
Weight loss (509)
Women's health (112)
Worklife (20)
Date
Today (73)
Last 7 days (493)
Last 30 days (2663)
Last 365 days (28901)
2026 (14410)
2025 (28724)
2024 (33050)
2023 (36975)
2022 (47770)
2021 (51251)
2020 (49040)
2019 (41375)
2018 (31209)
2017 (28929)
2016 (27372)
2015 (32040)
2014 (24526)
2013 (19718)
2012 (20882)
2011 (21843)
2010 (19719)
Location
Africa (733)
Alabama (91)
Alaska (4)
Arizona (283)
Arkansas (14)
Asia (37541)
Australia (7457)
California (12598)
Canada (3746)
China (1458)
Colorado (527)
Connecticut (527)
Delaware (422)
Europe (84619)
Florida (1925)
Georgia (388)
Hawaii (3)
Idaho (57)
Illinois (1003)
India (91)
Indiana (540)
Iowa (20)
Japan (557)
Kansas (123)
Kentucky (43)
Louisiana (57)
Maine (64)
Maryland (1548)
Massachusetts (9217)
Michigan (334)
Minnesota (664)
Mississippi (6)
Missouri (143)
Montana (29)
Nebraska (25)
Nevada (132)
New Hampshire (80)
New Jersey (3459)
New Mexico (28)
New York (3290)
North Carolina (1623)
North Dakota (8)
Northern California (6273)
Ohio (359)
Oklahoma (19)
Oregon (35)
Pennsylvania (2471)
Puerto Rico (26)
Rhode Island (45)
South America (986)
South Carolina (79)
South Dakota (2)
Southern California (5083)
Tennessee (192)
Texas (2047)
United States (44732)
Utah (376)
Vermont (1)
Virginia (300)
Washington D.C. (71)
Washington State (1046)
West Virginia (4)
Wisconsin (118)
Wyoming (2)
616,194 Results for "apim therapeutics as".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
March 25, 2026
·
3 min read
Press Releases
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
February 12, 2026
·
4 min read
Press Releases
Apimeds Brings ai² Futures Lab™ to the Palouse — Partnering with the University of Idaho to Shape the Future of Biotech Innovation
November 10, 2025
·
5 min read
Press Releases
Apimeds Welcomes FDA Draft Guidance as Catalyst for Advancing Apitox Non-Opioid Pain Program
September 12, 2025
·
3 min read
Press Releases
Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
May 12, 2025
·
5 min read
Press Releases
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
May 8, 2025
·
5 min read
Press Releases
Apimeds Expands Leadership Team with Dr. Susan Kramer to Lead Product Development and Brian Peters to Lead its ai² Division
July 16, 2025
·
5 min read
Deals
Nordic Nanovector comment on Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA desires to share more information with the Company’s shareholders about the proposed merger between the Company and APIM Therapeutics.
November 21, 2022
·
6 min read
Nordic Nanovector update following shareholder vote against proposed merger with APIM Therapeutics
Nordic Nanovector ASA (OSE: NANOV) (“Nordic Nanovector” or the “Company”) today announces an update following the Extraordinary General Meeting held on 1 December at which the proposed merger transaction with APIM Therapeutics AS (“APIM”) did not obtain a sufficient majority of votes and was therefore voted down.
December 9, 2022
·
2 min read
Deals
Nordic Nanovector Launches Dedicated Area on its Website in Norwegian for Information on the Proposed Merger with APIM Therapeutics
Nordic Nanovector ASA has today launched a new dedicated area on its website ( www.nordicnanovector.com ) with information in Norwegian for shareholders relating to its proposed merger with APIM Therapeutics (“APIM”).
November 25, 2022
·
6 min read
1 of 61,620
Next
